IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biodexa Pharmaceuticals Plc ADR

CUSIP: 59564R872 | 8 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AArmistice Capital, LLC26,16610.0%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/AArmistice Capital, LLC26,166
10.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

StoneX Group Inc.12,499
0.0% of portfolio›$8.4K
UBS Group AG1,786
0.0% of portfolio›$1.2K
SBI Securities Co., Ltd.19
0.0% of portfolio›$12
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
StoneX Group Inc.
12,499$8.4K0.0%ETFMediumNew York, NY2026-11-03
UBS Group AG
1,786$1.2K0.0%CoreMediumZurich, Switzerland2026-11-10
SBI Securities Co., Ltd.
19$120.0%GrowthLowTokyo, Mexico2026-10-22
Caitong International Asset Management Co., Ltd
1$10.0%GrowthVery HighHong Kong, South Korea2026-10-29
New 5%+ stake
No 13F filer matched